BioEquity Watch
BioEquity Watch is a free, independent publication offering in-depth analysis of biotech and pharmaceutical companies, focused on market-relevant research, IPOs, and drug development pipelines.
| Platform |  | Pricing | Only free issues | Publishes | Weekly |
|---|---|---|---|---|---|
| Issues | 65 | Founded | a year ago | Last Issue | 8 days ago |
| Active | |||||
Read this Newsletter
bioequitywatch.substack.comLatest Issues
Nuvation Bio ($NUVB) : The bane of rare cancers?
Rating: BULLISH | Target Price: $10.91 | Current Price: $6.10 | Implied Change: +78.85%
AUTHOR’S TAKE
We are bullish on Nuvation Bio ($ NUVB) because Wall Street values it like a high-burn, pre-revenue biotech, overlooking that it’s...
A Short Update
Good Morning Everyone!
I know that many people were expecting an article today morning as I usually try my best to post on Friday mornings. Unfortunately, life’s become really busy lately, and I’ll be modifying my schedule to post bi-weekl...
Can we CLIMB to the top? : An analysis of Climb Bio ($CLYM)
Rating: Speculative Buy | Target Price: $21.80 | Current Price: $15.52 | Implied Change: +40.46%
AUTHOR’S TAKE
Climb Bio should be rated a speculative buy because its solid clinical engineering faces an uphill battle against heavily...
Does it take 2 to tango, or just 1? : An Analysis of Tango Therapeutics ($TNGX)
Rating: BULLISH | Target Price: $47.92 | Current Price: $25.33 | Implied Change: +89.2%
AUTHOR’S TAKE
We are bullish on Tango Therapeutics ($TNGX) because Wall Street doesn’t understand how good its main medicine is. Because older, sim...
Ultragenyx: A $RARE Short?
Rating: BEARISH | Target Price: $16.00 | Current Price: $25.67 | Implied Change: -37.67%
AUTHOR’S TAKE
The market treats Ultragenyx like a diversified, safe-haven rare disease leader on the cusp of blockbuster commercial expansi...
Key Facts
Audience Metrics
Subscribers, engagement, traffic and sponsorship for BioEquity Watch.
| Subscribers | Engagement | 74 | Monthly Web Visits | ||
|---|---|---|---|---|---|
| Accepts Sponsors | Estimated Cost per Ad | ||||
Explore More
Authors
The writers behind this newsletter.
BioEquity Watch is a free, independent publication offering in-depth analysis of biotech and pharmaceutical companies, focused on market-relevant research, IPOs, and drug development pipelines.
Frequently Asked Questions
How can I access the email archive for BioEquity Watch?
You can find recent issues that have been published by BioEquity Watch on Reletter by scrolling up to where it says Latest Issues. Tap on the link for any of the most recent emails or hit More Issues to see older ones.
How many subscribers does BioEquity Watch have?
To see how many people subscribe to BioEquity Watch, simply upgrade your Reletter account. We provide readership numbers and lots of other stats for this newsletter so you can decide if it's worth reaching out to.
How can I advertise in BioEquity Watch?
Newsletter advertising can be extremely effective when it's done right. Before you pitch BioEquity Watch as a potential sponsor or partner, make sure that you've done your research and checked its newsletter stats with Reletter.
Then, personalize one of our winning pitching templates and send it to the right person using the contact info provided.
How much does it cost to sponsor a publication like BioEquity Watch?
Newsletter ad rates (or CPM) vary depending on many factors, including industry, number of subscribers, open rate, ad placement and more.
To find out how much an ad will cost, contact BioEquity Watch using the contact information provided and ask for a copy of their media kit.
How can I find newsletters related to BioEquity Watch?
Scroll up to where it says Related Newsletters to see other publications like BioEquity Watch. You can also search our email newsletter directory to discover other newsletters that cover the topics you're interested in.
How do I contact BioEquity Watch?
Reletter provides this newsletter's website URL above, where you will often find their contact information. We also provide links to associated social media accounts and pitching templates so you can reach out fast.